Harold Burstein: Thoughtful op-ed on multicancer ctDNA genomic screens by Hilary Robbins

Harold Burstein, Breast cancer specialist and Professor at Dana Farber Cancer Institute, shared a post on X about a recent paper by Hilary Robbins titled “Multicancer Early Detection Tests — Keeping a High Bar for Evidence of Benefit” published in The New England Journal of Medicine.

“Thoughtful op-ed on multicancer ctDNA genomic screens. Issues of false-reassurance, and on other side, positives without clinical cancers, are important to address.”

Source: Harold Burstein/X